Dynamequil: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Dynamequil
Largest movements
- Cash +€13,635
up €13,635 (+68.2%), from €20,008 to €33,643
mainly Current investments (+€9,993) and Trade debts (+€7,012)
- Current investments -€9,993
down €9,993 (-9.8%), from €101,981 to €91,988
- Receivables within one year +€7,772
up €7,772 (+57.6%), from €13,489 to €21,261
of which Trade receivables: +€7,301
- Trade debts +€7,012
up €7,012 (+4,919%), from €143 to €7,155
- Tax, wage and social debts +€2,290
up €2,290 (+44.8%), from €5,116 to €7,406
of which Taxes: +€2,256
- Profit (loss) carried forward +€2,173
up €2,173 (+2.1%), from €103,608 to €105,781
- Gross operating margin +€7,452
up €7,452, from -€2,528 to €4,924
- Taxes +€1,246
up €1,246, from -€5 to €1,242
- Financial income -€808
down €808 (-24.8%), from €3,259 to €2,451
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €135,547 | €146,961 | +€11,414 | +8.4% |
| Fixed assets | 21/28 | €70 | €70 | = | 0.0% |
| Financial fixed assets | 28 | €70 | €70 | = | 0.0% |
| Current assets | 29/58 | €135,477 | €146,891 | +€11,414 | +8.4% |
| Amounts receivable within one year | 40/41 | €13,489 | €21,261 | +€7,772 | +57.6% |
| Trade receivables | 40 | €13,489 | €20,790 | +€7,301 | +54.1% |
| Other amounts receivable | 41 | - | €471 | +€471 | |
| Current investments | 50/53 | €101,981 | €91,988 | -€9,993 | -9.8% |
| Cash at bank and in hand | 54/58 | €20,008 | €33,643 | +€13,635 | +68.2% |
| Total equity and liabilities | 10/49 | €135,547 | €146,961 | +€11,414 | +8.4% |
| Equity | 10/15 | €130,152 | €132,325 | +€2,173 | +1.7% |
| Contributions | 10/11 | €18,592 | €18,592 | = | 0.0% |
| Reserves | 13 | €7,952 | €7,952 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,859 | €1,859 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,859 | €1,859 | = | 0.0% |
| Distributable reserves | 133 | €6,093 | €6,093 | = | 0.0% |
| Profit (loss) carried forward | 14 | €103,608 | €105,781 | +€2,173 | +2.1% |
| Amounts payable | 17/49 | €5,395 | €14,636 | +€9,241 | +171% |
| Amounts payable within one year | 42/48 | €5,259 | €14,561 | +€9,303 | +177% |
| Trade debts | 44 | €143 | €7,155 | +€7,012 | +4,919% |
| Suppliers | 440/4 | €143 | €7,155 | +€7,012 | +4,919% |
| Taxes, remuneration and social security | 45 | €5,116 | €7,406 | +€2,290 | +44.8% |
| Taxes | 450/3 | €5,116 | €7,372 | +€2,256 | +44.1% |
| Remuneration and social security | 454/9 | - | €34 | +€34 | |
| Accrued charges and deferred income | 492/3 | €136 | €75 | -€61 | -44.9% |
| Other operating charges | 640/8 | €3,895 | €3,870 | -€25 | -0.6% |
| Gross operating margin | 9900 | -€2,528 | €4,924 | +€7,452 | |
| Operating profit (loss) | 9901 | -€6,423 | €1,054 | +€7,477 | |
| Financial income | 75/76B | €3,259 | €2,451 | -€808 | -24.8% |
| Recurring financial income | 75 | €3,259 | €2,451 | -€808 | -24.8% |
| Financial charges | 65/66B | €98 | €90 | -€8 | -7.7% |
| Recurring financial charges | 65 | €98 | €90 | -€8 | -7.7% |
| Profit (loss) for the period before taxes | 9903 | -€3,262 | €3,414 | +€6,677 | |
| Income taxes | 67/77 | -€5 | €1,242 | +€1,246 | |
| Profit (loss) for the period | 9904 | -€3,258 | €2,173 | +€5,430 | |
| Profit (loss) for the period to be appropriated | 9905 | -€3,258 | €2,173 | +€5,430 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.